Medical Devices Today

St. Jude CEO Compensation Falls 10 Percent Last Year

 

· Abbott, St. Jude, Others See Greater Device Sales Abroad

· Boston Sci Target Of Two Federal Probes Into Defibrillator Recall

· Boston Sci’s New CEO Got $33.5 Million Package For Six Months

· Siemens, GE, Others See Payback In Ultrasound Replacing Biopsies

· Ethicon Endo-Surgery Gets Offer To Buy Breast-Care Business

· Medtronic, AGA Settle Patent Suit With Medtronic To Get $35 Million

· Carl Zeiss Expects Year-End Report On Tests Of Radiotherapy Device

· Abbott, Medtronic, J&J Others Seek To Sell Both Insulin And Devices

· GE Request For Expanded CT Use Divides Scientists, FDA

· Medtronic Donates $2 Million In Defibrillators From Olympics Venues

· Boston Sci Denied Expedited FDA Review Of Recalled Defibrillators

· Medtronic Sued By CareFusion For Near-Monopoly Of Two Device Markets

· Baxter CEO Sees Compensation Fall By 15 Percent In 2009

Device Stakeholders Debate Whether FDA Can, Or Should, Revoke 510(k)s

Article reprinted from "The Gray Sheet" - March 29, 2010

FDA should have no reason to rescind 510(k) substantial equivalence decisions for marketed devices except in extreme cases of fraud, device industry lobbyists said in recent comments to FDA. Read more...

Device Prom Song: Looks Like We Made It

Full article reprinted from Start Up - February/March 2010

A year ago, things looked bleak everywhere, including devices. But investors and executives battened down the hatches, tightened their belts, and adopted every other conceivable austerity-tied cliché. Things now are beginning to look upa little. Read more...

Deals in Depth: January 2010

Article preview reprinted from IN VIVO -  February/March, 2010

Alliance dollars were low in January, with only three biopharma deals reaching a potential deal value of $100 million or more, led by Ipsen and Inspiration's collaboration in hemophilia, worth $518 million. The bigger M&A dollars were seen in the device and diagnostic sectors, including Medtronic's take-out of CV device firm Invatec and its affiliates for $500 million. Both biopharma and device financing were down compared with December. Read more...

Dealmaking in 2009: A Look Back and A Glance Ahead

Article preview reprinted from Medtech Insight - February 2010

This article was excerpted from "Top Device Stories of 2009: A Year of Economic Revival and Regulatory Risk," IN VIVO, January 2010. Read more...

FDA Questions Data Supporting ReGen's Menaflex Ahead Of 510(k) Re-Review

Article reprinted from "The Gray Sheet" - March 22, 2010

FDA raised concerns about the preclinical and clinical data used to support 510(k) clearance of ReGen Biologic's Menaflex knee repair device ahead of an unprecedented March 23 advisory panel to reconsider FDA's original clearance decision. Read more...

Boston Sci Recall Of Heart Devices Explained In Analyst Report

 

· Medtronic Past Enables It To Expand Easily For Sales Growth

· Medtronic, S&N See Impact Of New Device Tax, But To Different Degrees

· Zimmer Sued In Texas Federal Court Over Durom Cup Implant

· Medtronic, St. Jude Seen To Benefit From Boston Sci Heart Device Snag

· Stryker CEO Salary Flat For 2009, But Option Awards Give $3.9 Million

·  Covidien Awarded $4.8 Million In Patent Suit Against Applied Medical

· Kimberly-Clark Maps Plan To Offset Spending Expansion With Cuts

· Boston Sci Backed For Expanded Use Of Heart Defibrillator Under Recall

· Medtronic Gets FDA Panel Recommendation For MRI-Safe Pacemaker

· St. Jude Sued By Shareholders Alleging Misinformation About Sales

· Boston Sci Could Rebound From Defib Recall Within 30 Days, Analyst Says

· Medtronic Gets FDA Approval For Patient-Tailored Insulin Pump System

· J&J CEO Weldon Gets $30.8 Million In 2009 Compensation

A Special Report from “The Silver Sheet” When Is an iPhone a Medical Device?

A Special Report from “The Silver Sheet” When Is an iPhone a Medical Device? A special report from “The Silver Sheet” on increasing FDA regulation of consumer electronics and software used in medical devices and electronic health records.

FREE FOR A LIMITED TIME!

AMSH divests Her Option to CooperSurgical for $20.5mm

Deal summary reprinted from Strategic Transactions - February, 2010

Just months after selling off its Ovion Eclipse female sterilization assets to Conceptus, American Medical Systems Holdings (gynecological and urological devices) has now divested its Her Option global endometrial ablation product line to CooperSurgical (gynecological devices) for $20.5mm in cash. Read more...

Cardiac Imaging and CER: The Search for Efficiency

Article preview reprinted from Medtech Insight - February 2010

Regardless of the final shape of health care reform legislation, there is little doubt that the swirling debate around that issue has highlighted an unambiguous need to reduce health system costs, increase efficiency, and improve patient outcomes. This is particularly true for high-cost diagnostics in crucial areas like cardiac care. The focus on fast-rising care costs has ratcheted up the pressure to reduce the number and fine-tune the quality of cardiac imaging procedures. And perhaps nothing signifies change in this area more than the introduction of comparative effectiveness research into the equation in the search for standards of care. Read more...